当前位置: 首页 > 期刊 > 《健康必读·中旬刊》 > 20113
编号:13771237
米力农治疗脑动脉瘤蛛网膜下腔出血后脑血管痉挛疗效观察(2)
http://www.100md.com 2011年3月1日 李向
第1页

    参见附件。

     [4] Khajavi K, Ayzman I, Shearer D, Jones SC, Levy JH, Prayson RA,Skibinski CI, Hahn JF, Chyatte D. Prevention of chronic cerebral vasospasm in dogs with milrinone. Neurosurgery. 1997;40:354 –362.

    [5 ]Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: Report of seven cases. Neurosurgery. 2001;48:723–728.

    [6] Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354:387–396.

    [7] Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, Lee KS. Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation. Neurosurgery. 2003;53:123–133.

    [8]Muizelaar JP, Zwienenberg M, Rudisill NA, Hecht ST. The prophylactic use of transluminal balloon angioplasty in patients with fisher grade 3 subarachnoid hemorrhage: A pilot study. J Neurosurg. 1999;91:51–58.

    [9]Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF. Intraarteriallyadministered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery. 1998;42:1256 –1264.

    

您现在查看是摘要介绍页,详见PDF附件